ASAlida F. W. van der Steeg

Alida F. W. van der Steeg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alida F. W. van der Steeg has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Jan A. Roukema

    Centre of Research on Psychology in Somatic Disease (CoRPS) Department of Medical and Clinical Psychology Tilburg University Tilburg The Netherlands

    4 shared publications
  • Christien Sleeboom

    2 shared publications
  • Hugo A. Heij

    Paediatric Surgical Centre of Amsterdam, Emma Children's Hospital AMC & VU University Medical Centre, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands

    2 shared publications
  • Jolanda De Vries

    Department of Psychology and Health Medical Psychology, Tilburg University P.O. Box 90153 5000 LE Tilburg The Netherlands

    2 shared publications
  • Jolanda de Vries

    Centre of Research on Psychology in Somatic Disease (CoRPS) Department of Medical and Clinical Psychology Tilburg University Tilburg The Netherlands

    2 shared publications
  • Marlies C. Mertens

    Centre of Research on Psychology in Somatic Disease (CoRPS) Department of Medical and Clinical Psychology Tilburg University Tilburg The Netherlands

    2 shared publications

Latest Publications

  • The value of ultrasonography in boys with a non-palpable testis

    by Alexander Vos, Annebeth Meij-De Vries, Anne Smets, Jonathan Verbeke, Hugo Heij, Alida van der Steeg


  • The impact of diagnosis and trait anxiety on psychological distress in women with early stage breast cancer: A prospective study

    by Claudia M. G. Keyzer‐Dekker, Jolanda de Vries, Marlies C. Mertens, Jan A. Roukema, Alida F. W. van der Steeg

    Objectives: High trait anxiety ( HTA ) determines depressive symptoms and state anxiety in women with breast cancer ( BC ) or benign breast disease ( BBD ). Before implementing screening for psychological counselling in these women, it is important to evaluate whether high state anxiety and depressive symptoms are determined by (the threat of) having BC or solely by HTA . Therefore, we compared women with a lump in the breast with women with gallstone disease ( GD ). Methods: Women diagnosed with BC ( n  =   152), BBD ( n  =   205), and GD ( n  =   128) were included in a prospective longitudinal study. Questionnaires concerning trait anxiety (baseline), state anxiety, and depressive symptoms were completed before diagnosis was known ( BC and BBD ) or the laparoscopic cholecystectomy and 6 months later. Results: Pre‐diagnosis BC patients scored higher on state anxiety ( p  =   .001) and depressive symptoms ( p  <   .001) compared with GD . At 6 months, scores on depressive symptoms in BC remained higher than GD ( p  =   .005). In women with HTA , before being diagnosed with BC or BBD , scores on state anxiety were higher compared with HTA women with GD ( p  <   .001, p  =   .040). State anxiety and depressive symptoms at 6 months were predicted by baseline depressive symptoms in women with BC . Conclusions: The severity of diagnosis ( BC ) in combination with HTA determined the level of state anxiety and depressive symptoms. Therefore, we recommend identifying women with HTA and offering them a tailor‐made follow‐up protocol during and after the diagnostic process for BBD or BC . Statement of contribution: What is already known on this subject? Women diagnosed with BC or BBD experience high levels of anxiety and distress during the diagnostic process. These adverse psychological effects are strengthened by the personality characteristic trait anxiety. Before implementing screening for psychological counselling in women with high trait anixety, it is important to evaluate whether high state anxiety and depressive symptoms are determined by (the threat of) having BC or solely by HTA . What does this study add? To our knowledge, this is the first study comparing women who are confronted with the possibility of having a life‐threatening disease, that is, BC , with women who were not suspected of having a life‐threatening disease, that is, GD . This study reveals that the severity of diagnosis ( BC ) in combination with HTA determined the level of state anxiety and depressive symptoms. Therefore, we recommend identifying women with HTA and offering them a tailor‐made follow‐up protocol during and after the diagnostic process for BC or BBD .


  • Anxiety and Quality of Life of Parents with Children Diagnosed with an Anorectal Malformation or Hirschsprung Disease

    by Marieke Witvliet, Christine Sleeboom, Justin de Jong, Anton van Dijk, Sander Zwaveling, Alida van der Steeg

    Aim The aim of this study was to investigate the difference in anxiety and quality of life (QOL) between mothers and fathers of children with anorectal malformations (ARM) or Hirschsprung disease (HD). In addition, anxiety of parents of newborns was compared with parents of children in the age-group of 10 to 13 years. Methods Parents of 44 patients with ARM or HD completed the World Health Organization Quality of Life (WHOQOL)-BREF (26 items) and the Spielberger State-Trait Anxiety Inventory (STAI-trait 10 items, STAI-state 6 items). They were divided into two groups according to their children's age (0–4 years and 10–13 years). Results Overall mothers scored significantly worse than fathers on state anxiety (p = 0.005). Trait anxiety was not significantly different between mothers and fathers. The psychological domain of the WHOQOL-BREF was significantly different between parents (p = 0.016), with mothers scoring worse. Dividing the group in newborns and school going children mothers of newborns showed significantly more state anxiety compared with fathers of newborns (p = 0.016). In the group of older children, both anxiety and QOL were not significantly different between fathers and mothers. Comparing mothers of newborns with mothers of older children, the first group scored higher on state anxiety, but this difference was not significant (p = 0.138; 95% confidence interval, 0.535–3.717). Conclusions Mothers of newborns have a higher level of anxiety than fathers of newborns with ARM or HD. When children with ARM or HD become older, this difference in anxiety between parents is not significant anymore. This may be explained by coping strategies.


  • Cancer or No Cancer: The Influence of Trait Anxiety and Diagnosis on Quality of Life With Breast Cancer and Benign Disease: A Prospective, Longitudinal Study

    by Claudia M. G. Keyzer‐Dekker, Jolanda de Vries, Marlies C. Mertens, Jan A. Roukema, Alida F. W. van der Steeg

    Background: High trait anxiety (HTA) causes an impaired quality of life (QOL) and fatigue in women with breast cancer (BC) and benign breast disease (BBD). We examined whether the lowered QOL was determined solely by the personality characteristic HTA or by the combination of personality and diagnosis.Methods: In a prospective longitudinal study, women with BC (n = 152), BBD (n = 205), or gallstone disease (GD) before laparoscopic cholecystectomy (n = 128) were included. Questionnaires concerning trait anxiety (baseline), fatigue, and QOL were completed at baseline and at 6 months. Multivariate linear regression analysis was performed to analyze the predictors for QOL at 6 months.Results: At 6 months QOL scores were increased in the GD group, especially in women without HTA. For women without HTA, in the BBD group the scores for fatigue and physical QOL had improved at 6 months, whereas in the BC group physical QOL and fatigue was impaired. Women with HTA scored unfavorably on fatigue and QOL. HTA was the most important factor influencing QOL.Conclusions: The course of QOL and fatigue during follow‐up were significantly different for each diagnosis. Particularly HTA had a negative impact on QOL and fatigue. Especially the combination HTA and BC caused impaired QOL and fatigue. We recommend identifying women with BC and HTA and offer them a tailor‐made follow‐up protocol.


    • 1 January 2013
      • Vol. 157  (3) , A5633

    [The bubble-blowing neonate: a red flag for oesophageal atresia].

    by Esther Zwaan, Annebeth Meij-De Vries, Arend W Van Deutekom, Alida F W Van Der Steeg, Christien Sleeboom, Hugo A Heij

    When a newborn develops feeding difficulties, is blowing bubbles or has excessive saliva, it is important to consider the diagnosis of oesophageal atresia. Prenatal detection of oesophageal atresia is difficult. Postnatal bubble blowing, resulting from the inability to swallow excessive oropharyngeal secretions, is pathognomonic. These symptoms should trigger the midwife or physician to consider this diagnosis. We present three cases to illustrate the difficulties of early recognition and the consequences of a late detection of this condition. The first and third cases show that a delayed diagnosis of oesophageal atresia can lead to dangerous situations. Our second case illustrates that not every poorly drinking neonate has oesophageal atresia, and that this diagnosis may be rejected if the physician is able to pass a nasogastric tube. In every neonate who is unable to drink, we advise attempting to pass a nasogastric tube and taking a chest x-ray to distinguish between oesophageal atresia and other causes of feeding problems.

  • Open Access

    An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast disease

    by C. M. G. Keyzer-Dekker, L. van Esch, J. de Vries, M. F. Ernst, G. A. P. Nieuwenhuijzen, J. A. Roukema, A. F. W. van der Steeg

    Being recalled for further diagnostic procedures after an abnormal screening mammogram (ASM) can evoke a high state anxiety with lowered quality of life (QoL). We examined whether these adverse psychological consequences are found in all women with benign breast disease (BBD) or are particular to women referred after ASM. In addition, the influence of the anxiety as a personality characteristic (trait anxiety) was studied. Between September 2002 and February 2010 we performed a prospective longitudinal study in six Dutch hospitals. Women referred after ASM or with a palpable lump in the breast (PL), who were subsequently diagnosed with BBD, were included. Before diagnosis (at referral) and during follow-up, questionnaires were completed examining trait anxiety (at referral), state anxiety, depressive symptoms (at referral, one, three and 6 months after diagnosis), and QoL (at referral and 12 months). Women referred after ASM (N = 363) were compared with women with PL (N = 401). A similar state anxiety score was found in both groups, but a lower psychological QoL score at 12 months was seen in the ASM group. In women with not-high trait anxiety those in the ASM group were more anxious with more depressive symptoms at referral, and reported impaired psychological QoL at referral and at 12 months compared with the PL group. No differences were found between ASM and PL in women with high trait anxiety, but this group scored unfavorably on anxiety, depressive symptoms and QoL compared with women with not-high trait anxiety. ASM evokes more anxiety and depressive symptoms and lowered QoL compared with women referred with PL, especially in women who are not prone to anxiety. Women should be fully informed properly about the risks and benefits of breast cancer screening programs. We recommend identifying women at risk of reduced QoL using a psychometric test.


  • Open Access

    Effect of abnormal screening mammogram on quality of life

    by A F W van der Steeg, C M G Keyzer-Dekker, J De Vries, J A Roukema

    Background: Screening for breast cancer reduces breast cancer-related mortality. Advantages of screening are explained clearly, but its disadvantages are underrepresented in consent folders. Methods: In September 2002 a prospective, longitudinal study started concerning quality of life (QoL) in women with breast disease. Between September 2002 and January 2007, 385 women with an abnormal screening mammogram were included. Of these, 152 women were diagnosed with breast cancer (BC group) and 233 had a false-positive result (FP group). Questionnaires concerning anxiety (State and Trait Anxiety Inventory) and QoL (World Health Organization Quality of Life assessment instrument 100) were completed before diagnosis, and 1, 3, 6 and 12 months later. Results: The BC group was significantly older (60·2 versus 57·3 years; P < 0·001); significantly more histological biopsies were needed in the FP group (P < 0·001). Almost 60 per cent of the FP group revisited the outpatient clinic in the first year. Trait anxiety had a profound influence on QoL. Women in the FP group with a high score on trait anxiety had lowest QoL on all measurements (P < 0·001). They also reported more feelings of anxiety compared with women in the FP group with a lower trait anxiety score, and women in the BC group with a low trait anxiety score (P < 0·001). Conclusion: Women with a false-positive diagnosis of screen-detected breast cancer had a low QoL and feelings of anxiety, especially when they scored high on trait anxiety. This effect lasted for at least 1 year.


  • Open Access

    Effect of Surgery on Quality of Life with Operable Breast Cancer in Limited Resource Environments: Reply

    by Alida F. W. van der Steeg, Jolanda De Vries, Jan A. Roukema

  • Open Access

    Anxious Personality and Breast Cancer: Possible Negative Impact on Quality of Life After Breast‐Conserving Therapy

    by Alida F. W. van der Steeg, Jolanda De Vries, Jan A. Roukema

    Background: Quality of Life (QoL) is an important outcome measure in oncology. To assess the influence of surgical treatment and personality on QoL in women with breast cancer, a longitudinal prospective cohort study was done.Methods: Women (n = 222) completed questionnaires concerning QoL (WHOQOL 100) and personality (NEO‐FFI and STAI) prior to the diagnosis of breast cancer and 1, 3, 6, and 12 months after diagnosis and treatment. One hundred five women were treated with breast‐conserving therapy (BCT) and 117 women underwent mastectomy (MTC).Results: The two treatment groups did not differ on overall QoL. At all measurement times the influence of trait anxiety on overall QoL was substantial in the BCT group. Women with a high score on trait anxiety were seven times more likely to have a low overall QoL 1 year after BCT. In the MTC group overall QoL was influenced mainly by neuroticism.Conclusions: Personality, especially trait anxiety and neuroticism, determined patients’ overall QoL scores. Women with an anxious personality fared worse concerning QoL after breast conserving therapy.


    • 1 January 2009
      • Vol. 153, A191

    [Internally situated sacrococcygeal teratomas, often invisible but not harmless].

    by Alida F W Van Der Steeg, Christien Sleeboom, Hugo A Heij

    A sacrococcygeal teratoma (SCT) may be completely concealed within the pelvis and therefore not be visible externally. Symptoms of such an SCT can be very aspecific. We present 4 patients with an intrapelvic SCT. The first patient, a newborn girl, had an antenatally-diagnosed cystic mass in her pelvis, which was a benign SCT. After removal she suffered from neurogenic bladder dysfunction. The second patient was a 2-year-old boy who after two incomplete resections of a benign intrapelvic SCT, developed a malignant SCT. The other 2 patients, 2 girls aged 4 and 15 years, both presented with constipation and abdominal pain and were diagnosed as having an SCT. Early detection and radical excision, including removal of the os coccygis, are necessary to prevent development of malignancy. Long-term functional sequelae can occur after excision.